Joel E. Tepper, MD, the Hector MacLean Distinguished Professor of Cancer Research in the Department of Radiation Oncology wasbe one of twenty recipients of the American Society of Clinical Oncology (ASCO) 2011 Statesman Award.
The award, presented at ASCO’s Annual Meeting in early June in Chicago, IL, recognizes the extraordinary dedication of ASCO members for their voluntary efforts that benefit the Society, the specialty of oncology, and the patients served by the profession. Each year the award is given tovolunteers who have given 20 or more cumulative years of service to the Society.
Dr. Tepper shares the award with another outstanding Lineberger Comprehensive Cancer Center member, Richard M. Goldberg, MD, Distinguished Professor and Chief of the UNC Division of Hematology/Oncology, and Physician-in-Chief of the NC Cancer Hospital.
In Adaptive Radiation Therapy
Misty Lehman-Davis has become board-certified in Medical Dosimetry. Congratulations, Misty!
For a mouse model of the oncoprotein Mdm2.
Award recipients will be honored during the Biannual Meeting of the Medical Staff on May 31st at 5:00 pm in the 4th Floor Clinic Auditorium.
Dr. Higginson awarded with first annual Lineberger Clinical Fellow Award established to recognize UNC cancer trainees' outstanding accomplishments in both clinical and research endeavors.
Tonia Alston accepts coordinator position effective September 4, 2012.
Robert Adams gets Award of Excellence; Mahesh Varia, Elaine Zeman induced as Fellows
Developing the future of dosimetry education.
Are cancer cells are more sensitive to microbeam radiation than normal cells?
for Study in Biomedical Engineering.
In the June issue of the journal Cancer Cell.
Paper accept in Head & Neck
In comparing IMRT, Proton and conformal therapies, they conclude that IMRT is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence.